Literature DB >> 34269969

IgA nephropathy in adult-onset Still's disease after tocilizumab treatment: a case report.

Ji-Hyoun Kang1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34269969     DOI： 10.1007/s11255-021-02956-x

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


× No keyword cloud information.
  7 in total

Review 1.  [The kidney in Still's disease in adults].

Authors:  D Wendling; P Humbert; B Hory; D Blanc; J L Dupond; M Guidet
Journal:  Rev Rhum Mal Osteoartic       Date:  1989-03-15

2.  Preliminary criteria for classification of adult Still's disease.

Authors:  M Yamaguchi; A Ohta; T Tsunematsu; R Kasukawa; Y Mizushima; H Kashiwagi; S Kashiwazaki; K Tanimoto; Y Matsumoto; T Ota
Journal:  J Rheumatol       Date:  1992-03       Impact factor: 4.666

Review 3.  IgA nephropathy.

Authors:  Robert J Wyatt; Bruce A Julian
Journal:  N Engl J Med       Date:  2013-06-20       Impact factor: 91.245

Review 4.  Paradoxical reactions under TNF-α blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview.

Authors:  Éric Toussirot; François Aubin
Journal:  RMD Open       Date:  2016-07-15

5.  Development of glomerulonephritis during anti-TNF-alpha therapy for rheumatoid arthritis.

Authors:  Michael B Stokes; Kirk Foster; Glen S Markowitz; Farhang Ebrahimi; William Hines; Darren Kaufman; Brooke Moore; Daniel Wolde; Vivette D D'Agati
Journal:  Nephrol Dial Transplant       Date:  2005-04-19       Impact factor: 5.992

6.  Interleukin-6 localization and the prognosis of IgA nephropathy.

Authors:  Y Taniguchi; N Yorioka; J Kumagai; M Katsutani; M Kuratsune; D Amimoto; M Yamakido
Journal:  Nephron       Date:  1999-01       Impact factor: 2.847

Review 7.  Interleukin-6 Signaling Pathway and Its Role in Kidney Disease: An Update.

Authors:  Hua Su; Chun-Tao Lei; Chun Zhang
Journal:  Front Immunol       Date:  2017-04-21       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.